StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience operating margin

Operating margin is operating income as a percentage of revenue.

Zivo Bioscience's operating margin for the twelve months ending Sep 30, 2025 was -4045.7%. For fiscal 2024 it was -8498.9%, against -26267.7% the year before. The highest annual figure on record is -1865.7% in fiscal 2011.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-8498.9%+17768.8
FY2023Dec 31, 2023-26267.7%+16510.7
FY2020Dec 31, 2020-42778.4%−40912.7
FY2011Dec 31, 2011-1865.7%+3043.4
FY2010Dec 31, 2010-4909.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2025Sep 30, 2025-1551.8%+2020.0
Q2 FY2025Jun 30, 2025-3057.8%+13014.9
Q4 FY2024Dec 31, 2024-1773.8%+11551.5
Q3 FY2024Sep 30, 2024-7174.7%+37859.0
Q1 FY2024Mar 31, 2024-3571.8%+8458.8
Q4 FY2023Dec 31, 2023-16072.8%–
Q3 FY2023Sep 30, 2023-13325.3%–
Q2 FY2023Jun 30, 2023-45033.7%–
Q1 FY2020Mar 31, 2020-12030.6%–

More Zivo Bioscience figures

See a number that looks wrong?